Marquette Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.1K | Sell |
200
-350
| -64% | -$142K | 0.01% | 75 |
|
|
2025
Q1 | $274K | Sell |
550
-75
| -12% | -$37.3K | 0.05% | 46 |
|
|
2024
Q4 | $325K | Sell |
625
-10
| -2% | -$5.2K | 0.05% | 57 |
|
|
2024
Q3 | $393K | Buy |
635
+435
| +218% | +$269K | 0.06% | 54 |
|
|
2024
Q2 | $111K | Hold |
200
| – | – | 0.02% | 103 |
|
|
2024
Q1 | $116K | Hold |
200
| – | – | 0.02% | 107 |
|
|
2023
Q4 | $106K | Sell |
200
-25
| -11% | -$13.3K | 0.02% | 104 |
|
|
2023
Q3 | $114K | Hold |
225
| – | – | 0.03% | 95 |
|
|
2023
Q2 | $117K | Buy |
225
+25
| +13% | +$13K | 0.03% | 106 |
|
|
2023
Q1 | $115K | Hold |
200
| – | – | 0.03% | 104 |
|
|
2022
Q4 | $110K | Sell |
200
-331
| -62% | -$182K | 0.03% | 103 |
|
|
2022
Q3 | $269K | Sell |
531
-2
| -0.4% | -$1.01K | 0.08% | 54 |
|
|
2022
Q2 | $290K | Hold |
533
| – | – | 0.08% | 65 |
|
|
2022
Q1 | $315K | Buy |
533
+2
| +0.4% | +$1.18K | 0.07% | 76 |
|
|
2021
Q4 | $354K | Hold |
531
| – | – | 0.07% | 72 |
|
|
2021
Q3 | $303K | Hold |
531
| – | – | 0.07% | 76 |
|
|
2021
Q2 | $268K | Sell |
531
-5
| -0.9% | -$2.52K | 0.06% | 76 |
|
|
2021
Q1 | $245K | Hold |
536
| – | – | 0.06% | 77 |
|
|
2020
Q4 | $250K | Hold |
536
| – | – | 0.06% | 75 |
|
|
2020
Q3 | $237K | Hold |
536
| – | – | 0.07% | 62 |
|
|
2020
Q2 | $194K | Hold |
536
| – | – | 0.06% | 74 |
|
|
2020
Q1 | $152K | Buy |
536
+200
| +60% | +$56.7K | 0.06% | 78 |
|
|
2019
Q4 | $109K | Sell |
336
-25
| -7% | -$8.11K | 0.04% | 96 |
|
|
2019
Q3 | $105K | Buy |
361
+75
| +26% | +$21.8K | 0.04% | 98 |
|
|
2019
Q2 | $84K | Sell |
286
-51
| -15% | -$15K | 0.03% | 113 |
|
|
2019
Q1 | $92K | Buy |
+337
| New | +$92K | 0.03% | 107 |
|